Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease.

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor.

A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.

Targeting immune system proteins may keep prostate cancer from spreading to bone.

Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered.

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.